View in EDS HTML Full Text PDF Full Text

Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.

Saved in:
Bibliographic Details
Title: Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
Authors: Richeldi L; Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy., Schiffman C; Genentech, Inc., South San Francisco, California., Behr J; Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany., Inoue Y; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Corte TJ; Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia., Cottin V; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon, National Research Institute for Agriculture, Food and the Environment, European Reference Network for Rare Respiratory Diseases, Lyon, France., Jenkins RG; Imperial NIHR Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Nathan SD; Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia., Raghu G; University of Washington Medical Center, Seattle, Washington., Walsh SLF; Imperial NIHR Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Jayia PK; Roche Products Ltd., Welwyn Garden City, United Kingdom; and., Kamath N; Roche Products Ltd., Welwyn Garden City, United Kingdom; and., Martinez FJ; Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 May 01; Vol. 209 (9), pp. 1132-1140.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't; Multicenter Study
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38354066
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Richeldi+L%22">Richeldi L</searchLink>; Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Schiffman+C%22">Schiffman C</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Behr+J%22">Behr J</searchLink>; Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Inoue+Y%22">Inoue Y</searchLink>; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Corte+TJ%22">Corte TJ</searchLink>; Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Cottin+V%22">Cottin V</searchLink>; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon, National Research Institute for Agriculture, Food and the Environment, European Reference Network for Rare Respiratory Diseases, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Jenkins+RG%22">Jenkins RG</searchLink>; Imperial NIHR Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Nathan+SD%22">Nathan SD</searchLink>; Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia.<br /><searchLink fieldCode="AU" term="%22Raghu+G%22">Raghu G</searchLink>; University of Washington Medical Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Walsh+SLF%22">Walsh SLF</searchLink>; Imperial NIHR Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jayia+PK%22">Jayia PK</searchLink>; Roche Products Ltd., Welwyn Garden City, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Kamath+N%22">Kamath N</searchLink>; Roche Products Ltd., Welwyn Garden City, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Martinez+FJ%22">Martinez FJ</searchLink>; Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229421642%22">American journal of respiratory and critical care medicine</searchLink> [Am J Respir Crit Care Med] 2024 May 01; Vol. 209 (9), pp. 1132-1140.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Thoracic+Society%22">American Thoracic Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9421642 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-4970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221073449X%22">1073449X </searchLink><i>NLM ISO Abbreviation: </i>Am J Respir Crit Care Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38354066
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1164/rccm.202401-0116OC
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1132
    Titles:
      – TitleFull: Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Richeldi L
      – PersonEntity:
          Name:
            NameFull: Schiffman C
      – PersonEntity:
          Name:
            NameFull: Behr J
      – PersonEntity:
          Name:
            NameFull: Inoue Y
      – PersonEntity:
          Name:
            NameFull: Corte TJ
      – PersonEntity:
          Name:
            NameFull: Cottin V
      – PersonEntity:
          Name:
            NameFull: Jenkins RG
      – PersonEntity:
          Name:
            NameFull: Nathan SD
      – PersonEntity:
          Name:
            NameFull: Raghu G
      – PersonEntity:
          Name:
            NameFull: Walsh SLF
      – PersonEntity:
          Name:
            NameFull: Jayia PK
      – PersonEntity:
          Name:
            NameFull: Kamath N
      – PersonEntity:
          Name:
            NameFull: Martinez FJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1535-4970
          Numbering:
            – Type: volume
              Value: 209
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: American journal of respiratory and critical care medicine
              Type: main
ResultId 1